We're back at
World Clinical Biomarkers & CDx Boston!
Join us to explore how you can harness the power of decentralization to drive global health equity.
With our universal, scalable and technology-agnostic platform now serving 750 customers across 72 countries, coupled with our expertise in developing and deploying decentralized genomic applications, we help you enhance patient and market access to relevant genomic information, and match patients to the right trials and treatments.
Development of an NGS-based ecDNA detection solution into a clinical trial device targeting oncogene amplification
September 5, 2024 | 03:10 to 03:40 PM | Track A
SPEAKERS
 |
 |
 |
Julien Pontis PhD, Technical Product Manager and Lead Scientist, SOPHiA GENETICS |
Peter Krein PhD, Vice President of Precision Medicine, Boundless Bio |
David Lu PhD, Director of Precision Medicine, Boundless Bio |